Number 4: The top 5 biosimilar conference articles in 2024 highlight significant progress in the biosimilar landscape, including strategies for market sustainability, safety of switching to ...
To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug ...
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...
The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with ...
The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with projections indicating strong uptake in biosimilars at the expense of the ...
The 2024 surge in FDA approvals for aflibercept biosimilars reflects significant progress in offering cost-effective ...
The top 5 rheumatology biosimilar articles of 2024 focus on key developments in biosimilar approvals and treatment options. These include the FDA's approval of innovative formulations, such as a ...
On this episode of Not So Different, we reflect on 2024 and this show in particular, taking audiences back through the most popular podcast episodes of the year. The top 5 podcast episodes of the year ...
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...
The top biosimilar policy articles of 2024 highlight advancements that include FDA guidance to simplify biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback